|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 7/20/2015 11:10:08 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1117, Creating Access to Residency Education Act of 2015, all provisions
H.R. 2, Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, provision relating to Community Health Centers/GME
H.R. 2124, Resident Physician Shortage Reduction Act of 2015, all provisions
S. 1148, Resident Physician Shortage Reduction Act of 2015, all provisions
Graduate Medical Education
Student loan forgiveness
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1270, Restoring Access to Medication Act of 2015, all provisions
S. 709, Restoring Access to Medication Act of 2015, all provisions
H.R. 2652, Protecting Patients and Physicians Against Coding Act of 2015, all provisions
H.R. 2730, National Prostate Cancer Plan Act, all provisions
S. 216, National Prostate Cancer Plan Act, all provisions
S. 222, National Prostate Cancer Plan Act, all provisions
S. 1198, Improving the Integrity of Disability Evidence Act, all provisions
H.R. 2126, Cutting Costly Codes Act of 2015, all provisions
H.R. 6, 21st Century Cures Act, provisions relating to interoperability, registries, and data exchanges
H.R.270 - Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions
H.R. 2247, ICD-TEN Act, all provisions
H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions
S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act, all provisions
Affordable Care Act implementation
Drug Quality and Security Act implementation
In-office ancillary services exception
Drug Compounding
Health Savings Accounts - Prescription requirements for OTC medications
Indian Health Services - Purchased/Referred Care program
Interstate Medical Licensure Compact/Telemedicine
Immigration
Laboratory Developed Tests (LDTs)
NIH Funding for innovation
Prescription drug abuse
E-prescribing of controlled substances
DEA registration process
Opioid Misuse
Telemedicine
Health Information Technology/Meaningful Use
FDA regulation of powdered caffeine
Cybersecurity
FDA/NIH Modernization
Clinical Laboratory Improvement Act (CLIA) modernization
Hazardous drugs - handling in healthcare settings
National Pain Strategy
Pre-diabetes
Hypertension
HIPAA Administrative simplification (ICD-10, EFT, virtual credit cards)
ICD-10 transition
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Drug Enforcement Administration (DEA), Health & Human Services - Dept of (HHS), Office of Natl Drug Control Policy (NDCP), White House Office, Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Mari |
Savickis |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Charles |
Kels |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S. 1189, Conrad State 30 and Physician Access Act, all provisions
Conrad State 30 Visa Program
Antitrust
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1650, Medicare Patient Empowerment Act of 2015, all provisions
H.R. 2, Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, all provisions
H.R. 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions
S. 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions
H.R. 1892, Trade Adjustment Assistance (TAA) Reauthorization Act of 2015, provisions relating to Medicare Sequestration Offset
S. 1268, Trade Adjustment Assistance (TAA) Reauthorization Act of 2015, provisions relating to Medicare Sequestration Offset
H.R. 1295, Trade Preferences Extension Act of 2015, provisions relating to Medicare cuts
H.R. 1314, Trade Act of 2015, provisions relating to Medicare sequester
H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015, provisions relating to IPAB repeal
H.R. 1220, Removing Barriers to Colorectal Cancer Screening Act of 2015, all provisions
S. 624, Removing Barriers to Colorectal Cancer Screening Act of 2015, all provisions
S. 1549, Care Planning Act of 2015, all provisions
H.R. 2102, Medicare Diabetes Prevention Act of 2015, all provisions
S. 1131, Medicare Diabetes Prevention Act of 2015, all provisions
H.R. 2126, Cutting Costly Codes Act of 2015, all provisions
H.R. 1571, Improving Access to Medicare Coverage Act of 2015, all provisions
S. 843, Improving Access to Medicare Coverage Act of 2015, all provisions
H.R. 2404, Treat and Reduce Obesity Act of 2015, all provisions
S. 1509, Treat and Reduce Obesity Act of 2015, all provisions
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions
S. 1549, Care Planning Act of 2015, all provisions
H.R. 2247, ICD-TEN Act, all provisions
S. 488, A bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs, all provisions
H.R. 1021, Protecting the Integrity of Medicare Act of 2015, provisions relating to Medicare pharmacy and physician lock-in
Stopping Medication Abuse and protecting Seniors Act of 2015 draft legislation, provisions related to Medicare lock-in
Audit and Appeals Fairness, Integrity, and Reforms in Medicare Act of 2015 draft legislation
Medicare program: Alternate payment models, merit-based incentive payment systems
Medicare program: Two Midnights rule
Medicare program: Private Contracting
Medicare program: ICD-10 Repeal
Medicare program: SGR Repeal
Medicare program: ICD-10 transition
Medicare program: Payment Reform - Means Testing; Medigap Reform
Medicare program: EHR - Meaningful Use/Interoperability
Medicare program: Meaningful Use, Stage 3
Medicare program: Meaningful Use - Certification, Physician Quality Reporting System, Physician Compare, penalties
Medicare program: Advance care planning
Medicare program: Medicare Appeals Backlog
Medicare program: Recovery Audit Contractors
Medicare program: Part D Coverage
Medicare program: Part D Beneficiary Lock-in
Medicare program: Part B drug payment policies
Medicare program: Value-based Modifier
Medicare program: Relative Value Update Committee (RUC)
Medicare program: ICD-10 Implementation
Medicare program: Chronic Care
Medicare program: In-office Ancillary Services Exception
Medicare program: Program Integrity
Medicare program: Laboratory Developed Tests (LDTs)
Medicare program: Shared Savings Program - ACO regulations
Medicare program: Annual Wellness Visit
Medicare program: Telehealth
Medicare program: Quality measure development funding
Medicare program: Medicare Advantage/transparency and beneficiary and provider protections
Medicare program: Data Release
Medicare program: HIPAA Administrative simplification (ICD-10, EFT, virtual credit cards)
Medicare program: CLIA modernization
Medicare program: Graduate Medical Education
Medicare program: Global surgical services unbundling
Medicare program: Physician-owned hospitals
Medicare program: Sequester
Medicare program: Alternative payment models
Medicare program: Prescription drug diversion
Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act implementation
Medicare and Medicaid programs: Primary care payment
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), White House Office, Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Mari |
Savickis |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Charles |
Kels |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
S. 689, Sports Medicine Licensure Clarity Act, all provisions
H.R. 921, Sports Medicine Licensure Clarity Act, all provisions
H.R. 2603, Saving Lives, Saving Costs Act, provisions relating to medical liability reform
S. 1475, Saving Lives, Saving Costs Act, provisions relating to medical liability reform
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Charles |
Kels |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
TRICARE
Department of Veterans Affairs Health Care provider Hiring and Transferring Simplification Act draft bill, all provisions
17. House(s) of Congress and Federal agencies Check if None
Defense - Dept of (DOD), U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Charles |
Kels |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 2016 L-HHS Appropriations legislation, provisions relating to AHRQ and CMMI funding
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Margaret |
Garikes |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Tobacco
17. House(s) of Congress and Federal agencies Check if None
Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Margaret |
Garikes |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
CAW |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |